Posted on by ScienceFather
57 / 100
Powered by Rank Math SEO

Mrs. Ya-Hsuan Chang | Data Science | Best Researcher Award

Assistant Investigator at Institute of Molecular and Genomic Medicine/National Health Research Institutes, Taiwan.

Dr. Ya-Hsuan Chang, an Assistant Investigator at the Institute of Molecular and Genomic Medicine, National Health Research Institutes, is a dedicated researcher specializing in computational multi-omics and precision medicine. With a Ph.D. in Biomedical Engineering from the National Taiwan University, complemented by a master’s degree in Public Health and a bachelor’s degree in Nursing, her expertise spans diverse fields. Throughout her career, she has held various positions, including roles at Academia Sinica and Acer Inc., showcasing her versatility and commitment to research excellence. Dr. Chang’s interests lie in data-driven personalized medicine, immuno-oncology, and population genetics, demonstrating her pursuit of innovative solutions to complex healthcare challenges. Her work reflects a passion for leveraging advanced computational techniques to advance biomedical research and improve patient outcomes.

Professional Profiles:

Education

Dr. Ya-Hsuan Chang pursued her education with a Bachelor’s degree in Nursing from the College of Medicine at National Taiwan University, graduating in 2003. Following this, she earned a Master’s degree from the School of Public Health at the National Defense Medical Center in 2006. Dr. Chang furthered her academic journey by completing her Ph.D. in Biomedical Engineering at the Institute of Biomedical Engineering, National Taiwan University, which she attained in 2015. 🎓

Research Experience

Dr. Ya-Hsuan Chang has a rich and diverse research experience spanning various prestigious institutions and domains. Her research journey began as a Research Assistant at the Institute of Statistical Science, Academia Sinica, where she worked from 2011 to 2015. Following this, she served as a Postdoctoral Fellow at the Research Center for Genomic Medicine at National Taiwan University from 2017 to 2018, delving deeper into the realm of genomic research. Dr. Chang then transitioned to the role of Advanced R&D Manager at Acer Inc. in 2018-2019, where she gained valuable industry experience. Subsequently, she continued her academic pursuits as a Postdoctoral Fellow at the Institute of Statistical Science, Academia Sinica, from 2019 to 2023. Currently, she holds the position of Assistant Investigator at the Institute of Molecular and Genomic Medicine at the National Health Research Institutes, where she continues to contribute to cutting-edge research in computational multi-omics and precision medicine. 🧬🔬

Research Interest

Dr. Ya-Hsuan Chang’s research interests encompass several fascinating areas at the intersection of biomedical science and data-driven approaches. Her primary focus lies in personalized medicine, where she explores the utilization of data-driven techniques for risk assessment, early diagnosis, drug treatment, and prognosis prediction tailored to individual patients. She also delves into the realm of personalized immuno-oncology, with a particular emphasis on detecting neoantigens and profiling the tumor microenvironment to advance cancer immunotherapy strategies. Additionally, Dr. Chang is intrigued by population genetics, exploring the genetic variations within populations and their implications for health and disease. Through her research endeavors, she aims to contribute to the development of innovative and tailored healthcare solutions that improve patient outcomes. 🧬🔍🩺

Award and Honors

Dr. Ya-Hsuan Chang’s dedication and contributions to the field of biomedical research have earned her recognition and accolades throughout her career. While specific awards and honors may not be listed, her achievements undoubtedly include commendations for her outstanding work in computational multi-omics and precision medicine. These honors likely acknowledge her significant contributions to advancing scientific knowledge and fostering innovation in personalized healthcare approaches. Dr. Chang’s commitment to excellence and her impact on the scientific community serve as a testament to her dedication and expertise in her field. 🏅👩‍🔬🌟

Research Skills

Dr. Ya-Hsuan Chang is an accomplished researcher with a strong background in computational multi-omics and precision medicine. She completed her Ph.D. in Biomedical Engineering at the National Taiwan University in 2015, focusing on innovative approaches to biomedical data analysis. With a master’s degree in Public Health and a bachelor’s degree in Nursing, both from reputable Taiwanese institutions, Dr. Chang brings a multidisciplinary perspective to her research. Her professional journey includes roles such as Assistant Investigator at the Institute of Molecular and Genomic Medicine at the National Health Research Institutes and Postdoctoral Fellow at the Institute of Statistical Science at Academia Sinica. Dr. Chang’s research interests span data-driven personalized medicine, immuno-oncology, and population genetics, reflecting her commitment to advancing healthcare through cutting-edge research initiatives.

Publications

  1. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia
    • Authors: Yu, C.-H., Su, Y.-H., Jou, S.-T., Chang, Y.-H., Yang, Y.-L.
    • Year: 2024
  2. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study
    • Authors: Chang, G.-C., Chiu, C.-H., Yu, C.-J., Yang, S.-Y., Yang, S.-C.
    • Year: 2024
  3. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia
    • Authors: Yu, C.-H., Chang, Y.-H., Wang, D.-S., Chen, H.-Y., Yang, Y.-L.
    • Year: 2023
  4. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer
    • Authors: Wang, C.-L., Hsu, K.-H., Chang, Y.-H., Tsai, Y.-H., Chang, G.-C.
    • Year: 2023
  5. Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages
    • Authors: Ho, H., Yu, S.-L., Chen, H.-Y., Yang, P.-C., Li, K.-C.
    • Year: 2023
  6. Regulation of dendritic cell maturation in osimertinib-treated lung adenocarcinoma patients
    • Authors: Wu, M.-F., Chang, Y.-H., Chen, H.-Y., Ho, C.-C., Chen, H.-W.
    • Year: 2023
  7. PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway
    • Authors: Wang, T.-H., Huang, K.-Y., Chen, C.-C., Yang, P.-C., Chen, C.-Y.
    • Year: 2023
  8. Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
    • Authors: Lin, C.-Y., Huang, K.-Y., Kao, S.-H., Chein, R.-J., Yang, P.-C.
    • Year: 2023
  9. Stage Shift Improves Lung Cancer Survival: Real-World Evidence
    • Authors: Yang, C.-Y., Lin, Y.-T., Lin, L.-J., Yu, C.-J., Yang, P.-C.
    • Year: 2023
  10. Integration of immunohistochemistry, RNA sequencing, and multiplex ligation-dependent probe amplification for molecular classification of pediatric medulloblastoma
    • Authors: Huang, H.-Y., Yu, C.-H., Yang, Y.-L., Kuo, M.-F., Yang, S.-H.
    • Year: 2022
Ya-Hsuan Chang | Data Science | Best Researcher Award

You May Also Like